Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00921050Phase 3Completed
Phase 3, randomised, double-blind trial in hypothyroidism comparing Levothyroxine with Placebo (2 arms). Primary endpoints: Change in cognitive ability measured by NEUROPSI at 6 months, Left Ventricular Ejection Fraction at 6 months and 2 more. Started Jun 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00921050.